207 related articles for article (PubMed ID: 25724651)
41. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
[TBL] [Abstract][Full Text] [Related]
42. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
43. Pathogenic variants in AIMP1 cause pontocerebellar hypoplasia.
Accogli A; Russell L; Sébire G; Rivière JB; St-Onge J; Addour-Boudrahem N; Laporte AD; Rouleau GA; Saint-Martin C; Srour M
Neurogenetics; 2019 May; 20(2):103-108. PubMed ID: 30924036
[TBL] [Abstract][Full Text] [Related]
44. Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity purification-mass spectrometry reveals TARSL2 as a potential member of the complex.
Kim K; Park SJ; Na S; Kim JS; Choi H; Kim YK; Paek E; Lee C
PLoS One; 2013; 8(12):e81734. PubMed ID: 24312579
[TBL] [Abstract][Full Text] [Related]
45. Pro-EMAP II is not primarily cleaved by caspase-3 and -7.
Zhang FR; Schwarz MA
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1239-44. PubMed ID: 12003779
[TBL] [Abstract][Full Text] [Related]
46. Existence of two forms of rat liver arginyl-tRNA synthetase suggests channeling of aminoacyl-tRNA for protein synthesis.
Sivaram P; Deutscher MP
Proc Natl Acad Sci U S A; 1990 May; 87(10):3665-9. PubMed ID: 2187187
[TBL] [Abstract][Full Text] [Related]
47. Role of two aminoacyl-tRNA synthetase associated proteins (Endothelial Monocyte Activating Polypeptides 1 and 2) of Leishmania donovani in chemotaxis of human monocytes.
Tandon S; Muthuswami R; Madhubala R
Acta Trop; 2021 Dec; 224():106128. PubMed ID: 34509454
[TBL] [Abstract][Full Text] [Related]
48. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
[TBL] [Abstract][Full Text] [Related]
49. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
[TBL] [Abstract][Full Text] [Related]
50. Entamoeba lysyl-tRNA synthetase contains a cytokine-like domain with chemokine activity towards human endothelial cells.
Castro de Moura M; Miro F; Han JM; Kim S; Celada A; Ribas de Pouplana L
PLoS Negl Trop Dis; 2011 Nov; 5(11):e1398. PubMed ID: 22140588
[TBL] [Abstract][Full Text] [Related]
51. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase.
Wakasugi K; Schimmel P
J Biol Chem; 1999 Aug; 274(33):23155-9. PubMed ID: 10438485
[TBL] [Abstract][Full Text] [Related]
52. The activity of aminoacyl-tRNA synthetase-interacting multi-functional protein 1 (AIMP1) on endothelial cells is mediated by the assembly of a cytoskeletal protein complex.
Jackson VC; Dewilde S; Albo AG; Lis K; Corpillo D; Canepa B
J Cell Biochem; 2011 Jul; 112(7):1857-68. PubMed ID: 21416500
[TBL] [Abstract][Full Text] [Related]
53. Aminoacyl-tRNA synthetase complexes: beyond translation.
Lee SW; Cho BH; Park SG; Kim S
J Cell Sci; 2004 Aug; 117(Pt 17):3725-34. PubMed ID: 15286174
[TBL] [Abstract][Full Text] [Related]
54. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
55. Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.
Stathaki M; Armakolas A; Dimakakos A; Kaklamanis L; Vlachos I; Konstantoulakis MM; Zografos G; Koutsilieris M
Mol Med; 2014 Mar; 20(1):80-92. PubMed ID: 24395571
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
[TBL] [Abstract][Full Text] [Related]
57. Molecular determinants of the yeast Arc1p-aminoacyl-tRNA synthetase complex assembly.
Karanasios E; Simader H; Panayotou G; Suck D; Simos G
J Mol Biol; 2007 Dec; 374(4):1077-90. PubMed ID: 17976650
[TBL] [Abstract][Full Text] [Related]
58. Two distinct cytokines released from a human aminoacyl-tRNA synthetase.
Wakasugi K; Schimmel P
Science; 1999 Apr; 284(5411):147-51. PubMed ID: 10102815
[TBL] [Abstract][Full Text] [Related]
59. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia.
Quintos-Alagheband ML; White CW; Schwarz MA
Antioxid Redox Signal; 2004 Feb; 6(1):137-45. PubMed ID: 14713345
[TBL] [Abstract][Full Text] [Related]
60. EMAP II: a modulator of neovascularization in the developing lung.
Schwarz M; Lee M; Zhang F; Zhao J; Jin Y; Smith S; Bhuva J; Stern D; Warburton D; Starnes V
Am J Physiol; 1999 Feb; 276(2):L365-75. PubMed ID: 9950900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
